IMMvention is developing therapies that inhibit multiple inflammasome pathways that result in increased cytokine production that is at the root cause of some of the following diseases.

Biotechnology

IMMvention Therapeutix

Anil Goyal

Ryan Clark

Marilyn Thompson

J. David Becherer

The Research and Development Team at IMMvention Therapeutix is dedicated to innovating and advancing therapies that target multiple inflammasome pathways to reduce cytokine production. Comprising roles from Senior Scientist to Head of Chemistry, the team collaborates to research, design, and develop new therapeutic agents aimed at treating diseases driven by excessive cytokine activity.

Research and Development Team

About

Team members

Other teams at IMMvention Therapeutix

Leadership Team